Short description
BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.
Description
BioAffinity Technologies applies experience, intelligence and creativity to the global fight against cancer, the company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment.
The company uses technology that preferentially targets cancer cells and cell types indicative of a sick condition to produce exclusive noninvasive diagnostic tests and cancer therapies. The business is engaged in the development of technologies that, in the future, will be able to diagnose, track, and treat a variety of cancers, including lung ailments.
BioAffinity Technologies was established in 2014 in San Antonio, Texas.
Last funding
Nopepepe
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
San Antonio, Texas, United States, North America
Founded on
January 1, 2014
Exited on
September 1, 2022
Went public on
September 1, 2022
Stock symbol
BIAF
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Founders
Steven Cantor